• Study on the Safety and Effects of Fasudil Hydrochloride for Patients with Parkinson’s Disease

    Not recruiting

    2 1 1
    Germany
  • Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Greece Ireland Italy +2
  • Study of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency

    Not recruiting

    3 1 1
    France Germany Italy The Netherlands Portugal Spain
  • Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia Denmark Greece Hungary Poland Spain +1
  • Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Greece Italy Poland +3
  • Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Poland
  • Study on Levothyroxine and Sildenafil for Improving Erectile Function in Patients with Subclinical Hypothyroidism and Erectile Dysfunction

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Italy
  • Study of Eribulin for Adults with Advanced Solitary Fibrous Tumor in Second or Third Line Treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Gene Therapy with Atidarsagene Autotemcel for Patients with Metachromatic Leukodystrophy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

powered by